INDmoney
Genmab A/s Stock Performance
as on February 14, 2026 at 7:59 am IST
Day's Low
Day's High
$29.68$30.47
1.13%
Downside
1.50%
Upside
52 Week's Low
52 Week's High
$17.24$35.4342.59%
Downside
18.02%
Upside
Genmab A/s share price movements today
- Previous Close
- $29.59
- Open
- $29.68
- Volume
- 1.0M
- Day's Low - High
- $29.68 - $30.47
- 52 Week Low - High
- $17.24 - $35.43
Genmab A/s Historical Returns
- 1 Month Return
- -12.64 %
- 3 Month Return
- -2.15 %
- 1 Year Return
- + 41.44 %
- 3 Year Return
- -24.65 %
- 5 Year Return
- -27.17 %
Genmab A/s Stock Fundamentals & Key Indicators
Check Genmab A/s market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$18.5B
EPS (TTM)
1.9118
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
1.08%
PE Ratio (TTM)
13.18
Industry PE ratio
19.926794871794872
PEG Ratio
0.5795
EBITDA
1.5B
Revenue (TTM)
3.8B
Profit Margin
41.17%
Return On Equity TTM
29.41%
Genmab A/s Stock Valuation
Track how Genmab A/s P/E has moved over time to understand its valuation trends.
Genmab A/s in the last 5 years
Lowest (4.63x)
March 31, 2021
Today (13.18x)
February 13, 2026
Industry (19.93x)
February 13, 2026
Highest (64.13x)
September 30, 2021
Today’s Price to Earnings Ratio: 13.18x
Genmab A/s vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Genmab A/s with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $18.5B | -27.17% | 13.18 | 41.17% | |
| BUY | $118.3B | 117.32% | 32.46 | 31.35% | |
| NA | $38.9B | NA | 662.77 | 1.38% | |
| BUY | $42.5B | 95.34% | 1109.48 | 1.36% | |
| BUY | $82.4B | 61.37% | 18.8 | 31.41% |
Stock Returns calculator for Genmab A/s Stock including INR - Dollar returns
The Genmab A/s stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Genmab A/s investment value today
Current value as on today
₹1,48,007
Returns
₹48,007
(+48.01%)
Returns from Genmab A/s Stock
₹43,499 (+43.5%)
Dollar Returns*
₹4,507 (+4.51%)
Analyst Recommendation on Genmab A/s Stock
Based on 31 analysts
61.29%
Buy
29.03%
Hold
9.68%
Sell
Based on 31 analysts, 61.29% of analysts recommend a 'BUY' rating for Genmab A/s. Average target price of $37.93
Genmab A/s Share Price Target
Get share price movements and forecasts by analysts on Genmab A/s.
What analysts predicted
20.85%UPSIDE
Target Price
$37.93
Current Price
$30.02
Analyzed by
31 Analysts
Target
$37.93
Genmab A/s target price $37.93, a slight upside of 20.85% compared to current price of $30.02. According to 31 analysts rating.
Genmab A/s Stock’s Investor Sentiment and Interest
Search interest for Genmab A/s Stock has increased by 65% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:65% versus previous 30 day period
Genmab A/s Quarterly Profit & Loss
All numbers in Millions USD
Genmab A/s Annual Profit & Loss
All numbers in Millions USD
Genmab A/s Quarterly Cash Flow
All numbers in Millions USD
Genmab A/s Annual Cash Flow
All numbers in Millions USD
Genmab A/s News & Key Events
Today's Timeline - 11 December
Thu, 12:32 PM
-Genmab to hold 2025 R&D Update and ASH Data Review Meeting virtually on December 11, 2025.
Fri, 00:06 AM
-Transformative data and strategic investments position Genmab for growth and new product launches by 2027.
Insights on Genmab A/s
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 6 months, GMAB stock has moved up by 28.8%
NO EFFECTAgainst Peers
In the last 1 year, Beone Medicines Ltd has given 50.1% return, outperforming this stock by 11.2%
- NO EFFECT
Against Peers
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 43.5% return, outperforming this stock by 68.0%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 2.12B → 401.0M (in $), with an average decrease of 81.2% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 5.86B → 1.02B (in $), with an average decrease of 82.6% per quarter
About Genmab A/s
| Organisation | Genmab A/s |
| Headquarters | Carl Jacobsens Vej 30, Copenhagen, Denmark, 2500 |
| Industry | Health Technology |
| CEO | Dr. Jan G.J. van de Winkel Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Genmab A/s
Name | Title |
|---|---|
Mr. Martin Schultz | Senior Director, Head of Development Business Partnership & Strategy and Director |
Mr. Takahiro Hamatani | Senior Director of Finance Japan & Non-Independent Director |
Mr. Anthony Pagano CPA | Executive VP & CFO |
Mr. Rayne Waller | Executive VP & Chief Technical Operations Officer |
Mr. Christopher Cozic | Executive VP & Chief People Officer |
Dr. Martine J. van Vugt Ph.D. | Executive VP & Chief Strategy Officer |
Dr. Judith V. Klimovsky M.D. | Executive VP & Chief Development Officer |
Dr. Tahamtan Ahmadi M.D., Ph.D. | Executive VP, Chief Medical Officer & Head of Experimental Medicines |
Dr. Mijke Zachariasse Ph.D. | VP, Head of Antibody Research Materials & Director |
Dr. Jan G.J. van de Winkel Ph.D. | Co-Founder, President & CEO |
FAQs
What is Genmab A/s share price today?
Genmab A/s share price today is $30.02 as on at the close of the market. Genmab A/s share today touched a day high of $30.47 and a low of $29.68.
What is the 52 week high and 52 week low for Genmab A/s share?
Genmab A/s share touched a 52 week high of $35.43 on and a 52 week low of $17.24 on . Genmab A/s stock price today i.e. is closed at $30.02,which is 15.27% down from its 52 week high and 74.18% up from its 52 week low.
What is Genmab A/s's market capitalisation today?
Genmab A/s market capitalisation is $0.02T as on .
How to invest in Genmab A/s Stock (GMAB) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Genmab A/s on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Genmab A/s Shares that will get you 0.0500 shares as per Genmab A/s share price of $30.02 per share as on February 14, 2026 at 2:29 am IST.
What is the minimum amount required to buy Genmab A/s Stock (GMAB) from India?
Indian investors can start investing in Genmab A/s (GMAB) shares with as little as ₹90.608 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹906.08 in Genmab A/s stock (as per the Rupee-Dollar exchange rate as on ).
Based on Genmab A/s share’s latest price of $30.02 as on February 14, 2026 at 2:29 am IST, you will get 0.3331 shares of Genmab A/s. Learn more about
fractional shares .
What are the returns that Genmab A/s has given to Indian investors in the last 5 years?
Genmab A/s stock has given -27.17% share price returns and 24.74% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?